Literature DB >> 16044376

TLK-199 (Telik).

David Hamilton1, Gerald Batist.   

Abstract

Telik Inc is developing TLK-199, an intravenous inhibitor of glutathione S-transferase P1-1, for the potential prevention of myelosuppression in blood diseases, namely myelodysplastic syndrome.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16044376

Source DB:  PubMed          Journal:  IDrugs        ISSN： 1369-7056


  2 in total

1.  Development of Telintra as an Inhibitor of Glutathione S-Transferase P.

Authors:  Jie Zhang; Zhi-Wei Ye; Yvonne Janssen-Heininger; Danyelle M Townsend; Kenneth D Tew
Journal:  Handb Exp Pharmacol       Date:  2021

Review 2.  Role of glutathione in cancer progression and chemoresistance.

Authors:  Nicola Traverso; Roberta Ricciarelli; Mariapaola Nitti; Barbara Marengo; Anna Lisa Furfaro; Maria Adelaide Pronzato; Umberto Maria Marinari; Cinzia Domenicotti
Journal:  Oxid Med Cell Longev       Date:  2013-05-20       Impact factor: 6.543
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.